Y. Shi

发表

Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose‐lowering drugs: a subgroup analysis of the A1chieve study

G. Qin, Wenying Yang, Peng-qiu Li, 2014, Chinese medical journal.

Saxagliptin add‐on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double‐blind, placebo‐controlled trial

Ying-li Chen, L. Ji, Lixin Guo, 2018, Diabetes, obesity & metabolism.

The SEED study of dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial

L. Shi, G. Qin, Guixia Wang, 2021 .

Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial

P. Li, L. Shi, Xuefeng Yu, 2022, Nature Medicine.

Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.

Y. Bao, H. Tian, Guixia Wang, 2018, The lancet. Diabetes & endocrinology.

Efficacy and safety of once‐weekly dulaglutide in adult Chinese patients with type 2 diabetes and lower baseline body mass index

T. Hong, Jiankun Zhu, Si-ying Liu, 2020, Journal of diabetes.

Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial

Xuefeng Yu, Quanmin Li, Yongde Peng, 2022, Current medical research and opinion.

Efficacy and safety of high-dose esomeprazole–amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial

Donghong Yuan, Mingquan Li, Jiehong Wang, 2022, Chinese medical journal.

Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials

C. Schepers, Jie Shen, A. Plat, 2020, Diabetes Therapy.

Clinical expert consensus on the assessment and protection of pancreatic islet β-cell function in type 2 diabetes mellitus.

L. Shi, Q. Su, Li Chen, 2023, Diabetes research and clinical practice.

MiR-143 Targets IGF-1R to Suppress Autoimmunity in Thyroid-Associated Ophthalmopathy

J. Zou, Liangliang Sun, Jiao-yang Zheng, 2022, Journal of inflammation research.

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post‐hoc analyses of a randomized, double‐blind, phase III study

Lulu Chen, Quan-min Li, Liying Du, 2019, Journal of diabetes investigation.

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori

Y. Shi, Xingxing Chen, Hanxin Bi, 2022, Journal of digestive diseases.

Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial

Y. Shi, W. Shen, Qiang Dong, 2023, Chinese medical journal.

Combination Therapy with Metformin and Fenofibrate for Insulin Resistance in Obesity

Yanhua Xie, Y. Shi, Nanyan Zhang, 2011, The Journal of international medical research.